
09 Nov 2017 Governance
Leukaemia UK is the new name for the ‘Elimination of Leukaemia Fund’
Since November 2017 Leukaemia UK is the new name for the Elimination of Leukaemia Fund.
For the last four decades, Leukaemia UK has been making a difference to those living with blood cancer. We fund emotional support, pay for new hospital facilities, offer critical financial help and fund innovative research into better care and treatments for blood cancers.
We have used this, our 40th year, to review our work and achievements to develop a new strategy and vision for the future.
We want to increase our impact by supporting more families affected by blood cancer and by working with more hospitals around the UK.
Now feels like a good time to change our name from the Elimination of Leukaemia Fund to Leukaemia UK to reflect this ambition. We still hold tight to the founding principles of this charity which are:
- to improve care and support for people living with blood cancer
- to fund innovative research to find kinder, more effective ways of treating blood cancer
We have been fortunate to benefit from free consultancy from Frontera, a creative digital agency. The company has helped us develop a new name, logo and brand, at no cost to our supporters.
This new name encompasses our work as a leading blood cancer charity working for a blood cancer cure and improved care. Our work will remain the same, covering all blood cancers and related disorders.
Our name change won’t affect our charity registration number, office address, bank details and company numbers. For those who donate to us through payroll giving, standing order or direct debit, you won’t need to change anything.
We remain completely reliant on voluntary donations to keep our charity and its important work running. Thank you for your generous support and for being part of our exciting journey.
Find out more about:
- Our projects
- Our History
- Our work with King’s College Hospital in London
- Supporting you
- Ways to support us
Related posts
21 May 2020
A new clinical trial announced
A study into the impact of severe covid-19 infection on patients who receive stem cell transplants for blood cancers and blood disorders.
31 October 2023
Chris Dew joins Leukaemia UK as Director of Finances & Resources
Leukaemia UK is delighted to announce the appointment of Chris Dew as Director of Finance & Resources, following ten years as Chief Financial Officer at musical therapy charity Nordoff-Robbins. The…
17 April 2024
“Every little thing is gonna be alright” – three little birds tattoo marks mum’s recovery from one of the least survivable cancers
New research by Leukaemia UK which could reduce the side-effects of treatment for acute myeloid leukaemia (AML) welcomed by family affected by the disease. A family who was devastated when…
7 November 2022
Leukaemia UK appoints Ian McCafferty CBE as their new Chair of Trustees to support new strategy to stop leukaemia devastating lives
Ian McCafferty CBE will take up the role in January 2023, from current Chair of Trustees, Chris Corbin OBE, and will lead the charity as it continues to grow. Chris…